Imperial College London

Simon Erridge

Faculty of MedicineDepartment of Surgery & Cancer

Research Postgraduate







Block B Hammersmith HospitalHammersmith Campus





Simon is a medical doctor who graduated from Imperial College in 2018, also completing an intercalated BSc in Surgery and Anaesthesia. 

He holds an honorary clinical research fellowship at Imperial College and has worked on a number of innovative biotech opportunities throughout his career. His research interests include cannabis-based medicinal products, medical technologies, patient-reported outcome measures and population-based methodologies.



Erridge S, Sodergren MH, 2023, Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?, Inflammatory Bowel Diseases, ISSN:1078-0998

Rifkin-Zybutz R, Erridge S, Holvey C, et al., 2023, Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry, Psychopharmacology, Vol:240, ISSN:0033-3158, Pages:1735-1745

Wang C, Erridge S, Holvey C, et al., 2023, Assessment of clinical outcomes in patients with fibromyalgia: analysis from the UK Medical Cannabis Registry, Brain and Behavior, Vol:13, ISSN:2162-3279

Ergisi M, Erridge S, Harris M, et al., 2023, An updated analysis of clinical outcome measures across patients from the UK medical cannabis registry, Cannabis and Cannabinoid Research, Vol:8, ISSN:2378-8763, Pages:557-566

Erridge S, Mangoo S, Sodergren M, 2023, Letter to the editor: reflections on the future of medical cannabis research for depression, Expert Review of Neurotherapeutics: a Key Contribution to Decision Making in the Treatment of Neurologic and Neuropsychiatric Disorders, ISSN:1473-7175

More Publications